• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates

  • in General Medicine
  • — 21 Sep, 2007
DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
AudioMedica News
DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-359"/>
Pedro Cahn
Pedro Cahn

REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires
Etravirine provides a chance to rescue patients who are failing non-nucleoside regimens according to 24-week pooled results of the DUET-1 and -2 studies. Nicola Solomon discussed these major trials with Pedro Cahn, of Juan A. Fernández Hospital in Buenos Aires.

[audio:https://www.audiomedica.com/podcasting/general_medicine/070919PedroCahn.mp3]

You may also like...

  • Better Treatment for Addicts: New Urine Test for Street Heroin Better Treatment for Addicts: New Urine Test for Street Heroin 3 Jan, 2006
  • Gene Study Identifies Heart Disease Risk Gene Study Identifies Heart Disease Risk 29 Aug, 2007
  • Mandeep Mehra MD COVID-19 Co-Morbidity Risks Quantified from Three Continents Survey 28 May, 2020
  • Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma? Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma? 27 Feb, 2008

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Hospital Hand Hygiene Program Successfully Rolled Out
  • Next story Broad Approach, Including Computer System, to Improve Hospital Hygiene
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Venetoclax Pro-Apoptotic Therapy Benefits Older…
    • New Front Line Standard for Older Patients with…
    • Childhood Obesity—Whose Business Is It?
  • Home
  • General Medicine
  • DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates

© COPYRIGHT 2020 AUDIOMEDICA.COM.